Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule

EU orphan designation number: EU/3/06/411   
Active ingredient: Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule
Indication: Prevention of Graft-versus-Host disease
Sponsor: Apogenix GmbH
Im Neuenheimer Feld 584, D-69120 Heidelberg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/11/2006 Centralised Orphan - Designation EMEA/OD/054/06 (2006)5352 of 31/10/2006